Caitlin A. Finney

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2026

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 04, 2026

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.

Journal: bioRxiv : the preprint server for biology

Published: December 22, 2025

Mild cognitive impairment cases affect the predictive power of Alzheimer's disease diagnostic models using routine clinical variables.

Mild cognitive impairment cases affect the predictive power of Alzheimer's disease diagnostic models using routine clinical variables.

Journal: npj aging

Published: December 20, 2025

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Journal: Research square

Published: July 25, 2025

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.

Journal: Frontiers in psychiatry

Published: July 14, 2025

Highlights of 2024: Beyond lipids: immune dysfunction in APOE4-associated Alzheimer's disease.

Highlights of 2024: Beyond lipids: immune dysfunction in APOE4-associated Alzheimer's disease.

Journal: Immunology and cell biology

Published: April 30, 2025

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

Journal: Nature medicine

Published: April 24, 2025

APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases.

APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases.

Journal: Nature medicine

Published: April 20, 2025

A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration.

A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration.

Journal: Frontiers in immunology

Published: October 21, 2024

Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and Australia.

Developing multifactorial dementia prediction models using clinical variables from cohorts in the US and Australia.

Journal: Translational psychiatry

Published: July 04, 2024

Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.

Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: September 16, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026